Tae Sung Sohn

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

Răzvan Cristescu, Jeeyun Lee, Michael Nebozhyn et al. · Nature Medicine · 2015 · 2.2K citations

Medicine, Molecular Biology, Oncology +16

Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial

Jeeyun Lee, Do Hoon Lim, Sung Kim et al. · Journal of Clinical Oncology · 2011 · 812 citations

Medicine, Oncology, Surgery +17

Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses

Se Hoon Park, Tae Sung Sohn, Jeeyun Lee et al. · Journal of Clinical Oncology · 2015 · 429 citations

Medicine, Oncology, Surgery +17

An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach

Sung Kim, Do Hoon Lim, Jeeyun Lee et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 290 citations

Medicine, Oncology, Surgery +17

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆

S.H. Park, D.H. Lim, Tae Sung Sohn et al. · Annals of Oncology · 2020 · 286 citations · Full text

Medicine, Oncology, Surgery +17